300244 迪安诊断
已收盘 10-27 15:00:00
资讯
新帖
简况
研报掘金丨华鑫证券：首予迪安诊断“买入”评级，效益显著提升，合作布局智能体
格隆汇 · 17:24
研报掘金丨华鑫证券：首予迪安诊断“买入”评级，效益显著提升，合作布局智能体
华鑫证券：首次覆盖迪安诊断给予买入评级
证券之星 · 12:32
华鑫证券：首次覆盖迪安诊断给予买入评级
迪安诊断（300244）披露控股股东及其一致行动人股份触及1%整数倍公告，10月23日股价上涨2.36%
证券之星 · 10-23
迪安诊断（300244）披露控股股东及其一致行动人股份触及1%整数倍公告，10月23日股价上涨2.36%
迪安诊断（300244）披露控股股东及其一致行动人股份触及1%整数倍的公告，10月21日股价上涨3.49%
证券之星 · 10-21
迪安诊断（300244）披露控股股东及其一致行动人股份触及1%整数倍的公告，10月21日股价上涨3.49%
迪安诊断（300244）2026年三季报简析：净利润同比增长750.28%，盈利能力上升
证券之星 · 10-21
迪安诊断（300244）2026年三季报简析：净利润同比增长750.28%，盈利能力上升
迪安诊断(300244)9月30日股东户数4.52万户，较上期减少12.43%
证券之星 · 10-20
迪安诊断(300244)9月30日股东户数4.52万户，较上期减少12.43%
迪安诊断（300244）披露2026年第三季度报告，10月19日股价下跌2.52%
证券之星 · 10-19
迪安诊断（300244）披露2026年第三季度报告，10月19日股价下跌2.52%
迪安诊断前三季度净利润约4.82亿元，同比增长750.28%
北京商报 · 10-19
迪安诊断前三季度净利润约4.82亿元，同比增长750.28%
图解迪安诊断三季报：第三季度单季净利润同比增长438.03%
证券之星 · 10-19
图解迪安诊断三季报：第三季度单季净利润同比增长438.03%
迪安诊断（300244）10月16日主力资金净卖出4170.80万元
证券之星 · 10-19
迪安诊断（300244）10月16日主力资金净卖出4170.80万元
未及时披露独董述职报告 迪安诊断及董秘被采取行政监管措施
滚动播报 · 10-17
未及时披露独董述职报告 迪安诊断及董秘被采取行政监管措施
迪安诊断：副总经理陶钧因未及时披露公司重大事件等违规行为被浙江证监局出具警示函
证券之星 · 10-16
迪安诊断：副总经理陶钧因未及时披露公司重大事件等违规行为被浙江证监局出具警示函
迪安诊断：10月14日董事陈海斌减持股份合计131.09万股
证券之星 · 10-15
迪安诊断：10月14日董事陈海斌减持股份合计131.09万股
迪安诊断（300244）10月13日主力资金净卖出2585.64万元
证券之星 · 10-14
迪安诊断（300244）10月13日主力资金净卖出2585.64万元
迪安诊断（300244）10月12日主力资金净买入7359.28万元
证券之星 · 10-13
迪安诊断（300244）10月12日主力资金净买入7359.28万元
迪安诊断（300244）披露独立董事任期届满辞职公告，9月30日股价上涨1.63%
证券之星 · 09-30
迪安诊断（300244）披露独立董事任期届满辞职公告，9月30日股价上涨1.63%
港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作
智通财经 · 09-30
港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作
股市必读：迪安诊断新发布《2026年第一次临时股东会决议公告》
证券之星 · 09-28
股市必读：迪安诊断新发布《2026年第一次临时股东会决议公告》
迪安诊断（300244）披露2026年第一次临时股东会决议公告，9月24日股价下跌1.33%
证券之星 · 09-24
迪安诊断（300244）披露2026年第一次临时股东会决议公告，9月24日股价下跌1.33%
迪安诊断新注册《迪安诊断Repilot文献智搜平台V1.0》项目的软件著作权
证券之星 · 09-11
迪安诊断新注册《迪安诊断Repilot文献智搜平台V1.0》项目的软件著作权
加载更多
公司概况
公司名称：
迪安诊断技术集团股份有限公司
所属行业：
卫生
上市日期：
2011-07-19
主营业务：
迪安诊断技术集团股份有限公司的主营业务是医学诊断服务及体外诊断产品销售。公司的主要产品是医学诊断服务、诊断技术研发、诊断产品生产及销售、司法鉴定、健康管理。
发行价格：
23.50
{"stockData":{"symbol":"300244","market":"SZ","secType":"STK","nameCN":"迪安诊断","latestPrice":20.25,"timestamp":1793084583000,"preClose":21.3,"halted":0,"volume":47415318,"delay":0,"changeRate":-0.0493,"floatShares":501000000,"shares":625000000,"eps":0.7513,"marketStatus":"已收盘","change":-1.05,"latestTime":"10-27 15:00:00","open":21.65,"high":21.7,"low":20.2,"amount":984000000,"amplitude":0.0704,"askPrice":20.26,"askSize":560,"bidPrice":20.25,"bidSize":248,"shortable":0,"etf":0,"ttmEps":0.7513,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793151000000},"marketStatusCode":5,"adr":0,"adjPreClose":21.3,"symbolType":"stock","openAndCloseTimeList":[[1793064600000,1793071800000],[1793077200000,1793084400000]],"highLimit":23.43,"lowLimit":19.17,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":624979436,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":26.953281,"roe":"7.32%","epsLYR":0.0721,"committee":0.586762,"marketValue":12656000000,"turnoverRate":0.0946,"status":1,"floatMarketCap":10154000000},"requestUrl":"/m/hq/s/300244","defaultTab":"news","newsList":[{"id":"2678281122","title":"研报掘金丨华鑫证券：首予迪安诊断“买入”评级，效益显著提升，合作布局智能体","url":"https://stock-news.laohu8.com/highlight/detail?id=2678281122","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678281122?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:24","pubTimestamp":1793093068,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0146","BK0028","BK0186","BK0042","161027","BK0197","300244","BK0236","BK0070","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678514443","title":"华鑫证券：首次覆盖迪安诊断给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678514443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678514443?lang=zh_cn&edition=full","pubTime":"2026-10-27 12:32","pubTimestamp":1793075521,"startTime":"0","endTime":"0","summary":"华鑫证券有限责任公司胡博新近期对迪安诊断进行研究并发布了研究报告《公司事件点评报告：效益显著提升，合作布局智能体》，首次覆盖迪安诊断给予买入评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为24.55。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700021585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677703940","title":"迪安诊断（300244）披露控股股东及其一致行动人股份触及1%整数倍公告，10月23日股价上涨2.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677703940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677703940?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:53","pubTimestamp":1792749196,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，迪安诊断报收于21.66元，较前一交易日上涨2.36%，最新总市值为135.37亿元。近日，迪安诊断技术集团股份有限公司发布公告称，公司控股股东陈海斌及其一致行动人杭州迪安控股有限公司因股份减持导致合计持股比例下降1%。2026年10月21日，杭州迪控通过大宗交易减持3,530,000股，占总股本的0.5648%。本次变动后，双方合计持股由163,578,825股降至160,048,825股，占总股本比例由26.17%降至25.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300032349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0042","BK0146","BK0070","BK0197","BK0186","BK0236","300244","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677987677","title":"迪安诊断（300244）披露控股股东及其一致行动人股份触及1%整数倍的公告，10月21日股价上涨3.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677987677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677987677?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:01","pubTimestamp":1792591278,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，迪安诊断报收于22.55元，较前一交易日上涨3.49%，最新总市值为140.93亿元。公司于近日披露《关于控股股东及其一致行动人股份触及1%整数倍的公告》。公告显示，迪安诊断技术集团股份有限公司于2026年10月13日至20日，控股股东陈海斌及其一致行动人杭州迪安控股有限公司通过集中竞价和大宗交易方式合计减持公司股份8,496,498股，占公司总股本的1.3595%。本次减持后，双方合计持股比例由27.5330%下降至26.1735%，触及1%整数倍变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","BK0186","BK0042","BK0146","BK0197","BK0070","BK0028","BK0236","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677614748","title":"迪安诊断（300244）2026年三季报简析：净利润同比增长750.28%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2677614748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677614748?lang=zh_cn&edition=full","pubTime":"2026-10-21 06:04","pubTimestamp":1792533882,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期迪安诊断发布2026年三季报。截至本报告期末，公司营业总收入74.09亿元，同比下降2.07%，归母净利润4.82亿元，同比上升750.28%。本报告期迪安诊断盈利能力上升，毛利率同比增幅4.63%，净利率同比增幅254.11%。去年的净利率为1.44%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100004148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676669508","title":"迪安诊断(300244)9月30日股东户数4.52万户，较上期减少12.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676669508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676669508?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:23","pubTimestamp":1792488195,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迪安诊断披露，截至2026年9月30日公司股东户数为4.52万户，较6月30日减少6412.0户，减幅为12.43%。在医疗服务行业个股中，迪安诊断股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.67万户。从股价来看，2026年6月30日至2026年9月30日，迪安诊断区间涨幅为9.5%，在此期间股东户数减少6412.0户，减幅为12.43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000026233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0236","BK0042","BK0114","BK0186","BK0146","BK0197","BK0070","300244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676516684","title":"迪安诊断（300244）披露2026年第三季度报告，10月19日股价下跌2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676516684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676516684?lang=zh_cn&edition=full","pubTime":"2026-10-19 22:33","pubTimestamp":1792420399,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，迪安诊断报收于18.16元，较前一交易日下跌2.52%，最新总市值为113.5亿元。该股当日开盘18.34元，最高18.77元，最低17.68元，成交额达5.45亿元，换手率为6.0%。近日，迪安诊断技术集团股份有限公司召开第五届董事会第二十二次会议，审议通过《关于<2026年第三季度报告>的议案》。公司2026年第三季度报告已于2026年10月20日在中国证监会指定的创业板信息披露网站巨潮资讯网披露，供投资者查阅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900030177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","BK0114","BK0070","BK0186","BK0042","BK0028","BK0146","BK0236","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676869696","title":"迪安诊断前三季度净利润约4.82亿元，同比增长750.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676869696","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676869696?lang=zh_cn&edition=full","pubTime":"2026-10-19 20:23","pubTimestamp":1792412580,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！迪安诊断发布2026年三季报显示，公司前三季度实现营业收入约74.09亿元，同比下降2.07%；归属净利润约4.82亿元，同比增长750.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-19/doc-inivumaf7702429.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-19/doc-inivumaf7702429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676460507","title":"图解迪安诊断三季报：第三季度单季净利润同比增长438.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676460507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676460507?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:33","pubTimestamp":1792406010,"startTime":"0","endTime":"0","summary":"证券之星消息，迪安诊断2026年三季报显示，前三季度公司主营收入74.09亿元，同比下降2.07%；归母净利润4.82亿元，同比上升750.28%；扣非净利润4.18亿元，同比上升1074.8%；其中2026年第三季度，公司单季度主营收入26.35亿元，同比上升0.23%；单季度归母净利润2.5亿元，同比上升438.03%；单季度扣非净利润1.79亿元，同比上升299.38%；负债率35.64%，投资收益8341.95万元，财务费用9470.82万元，毛利率30.42%。财报数据概要请见下图:本文数据来源于迪安诊断2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900023687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676571313","title":"迪安诊断（300244）10月16日主力资金净卖出4170.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676571313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676571313?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:18","pubTimestamp":1792372690,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月16日收盘，迪安诊断报收于18.63元，下跌2.56%，换手率7.79%，成交量39.08万手，成交额7.5亿元。近5日资金流向一览见下表：迪安诊断融资融券信息显示，融资方面，当日融资买入6897.66万元，融资偿还6545.04万元，融资净买入352.62万元。迪安诊断主营业务：医学诊断服务、诊断技术研发、诊断产品生产及销售、司法鉴定、健康管理等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0070","BK0236","300244","BK0186","BK0042","BK0197","BK0028","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676545413","title":"未及时披露独董述职报告 迪安诊断及董秘被采取行政监管措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2676545413","media":"滚动播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676545413?lang=zh_cn&edition=full","pubTime":"2026-10-17 13:08","pubTimestamp":1792213680,"startTime":"0","endTime":"0","summary":"迪安诊断10月16日发布的公告显示，公司及董事会秘书陶钧于当日收到浙江证监局出具的行政监管措施决定书；同日，深交所创业板公司管理部也因同一违规事实对迪安诊断及陶钧下发监管函。对于未及时披露的原因，迪安诊断在公告中解释称，公司于2026年4月20日召开第五届董事会第十八次会议，因信息披露公告上传环节工作疏漏，未及时披露三位独立董事的述职报告。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-17/doc-inivpfyi7200313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0186","BK0197","300244","BK0236","BK0114","BK0042","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675159981","title":"迪安诊断：副总经理陶钧因未及时披露公司重大事件等违规行为被浙江证监局出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2675159981","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675159981?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:01","pubTimestamp":1792148460,"startTime":"0","endTime":"0","summary":"证券之星消息，10月16日迪安诊断公开信息显示，副总经理陶钧因未及时披露公司重大事件,未依法履行其他职责被浙江证监局出具警示函。详细违规行为如下：我局在日常监管中发现,迪安诊断技术集团股份有限公司存在未及时办理披露独立董事2025年度述职报告的情形,你作为董事会秘书,违反了《上市公司信息披露管理办法》(证监会令第226号)第三十九条第一款、第五十二条第一款的规定,对上述违规行为承担主要责任。处罚决定如下：采取出具警示函的监督管理措施,并记入证券期货市场诚信档案以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600033732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0070","BK0236","300244","BK0186","BK0042","BK0197","BK0028","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675658717","title":"迪安诊断：10月14日董事陈海斌减持股份合计131.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675658717","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675658717?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:01","pubTimestamp":1792069277,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月15日市场公开信息、上市公司公告及交易所披露数据整理，迪安诊断最新董监高及相关人员股份变动情况：2026年10月14日公司董事,高管陈海斌共减持公司股份131.09万股，占公司总股本为0.2098%。迪安诊断近半年内的董监高及核心技术人员增减持详情如下：迪安诊断的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入3752.27万，融资余额增加；融券净流出1.94万，融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500037911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0114","BK0028","BK0070","BK0197","BK0146","BK0042","300244","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399679","title":"迪安诊断（300244）10月13日主力资金净卖出2585.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399679?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:16","pubTimestamp":1791940581,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，迪安诊断报收于20.56元，下跌2.1%，换手率7.36%，成交量36.9万手，成交额7.49亿元。近5日资金流向一览见下表：迪安诊断融资融券信息显示，融资方面，当日融资买入8728.84万元，融资偿还7199.26万元，融资净买入1529.59万元。融券方面，融券卖出3600.0股，融券偿还11.08万股，融券余量11.73万股，融券余额241.17万元。迪安诊断主营业务：医学诊断服务、诊断技术研发、诊断产品生产及销售、司法鉴定、健康管理等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0186","BK0146","300244","BK0197","BK0042","BK0236","BK0114","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675389935","title":"迪安诊断（300244）10月12日主力资金净买入7359.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675389935","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675389935?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:05","pubTimestamp":1791853541,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，迪安诊断报收于21.0元，上涨2.94%，换手率10.99%，成交量55.1万手，成交额11.66亿元。近5日资金流向一览见下表：迪安诊断融资融券信息显示，融资方面，当日融资买入1.08亿元，融资偿还7828.11万元，融资净买入2945.34万元。融券方面，融券卖出13.24万股，融券偿还4600.0股，融券余量22.45万股，融券余额471.45万元。迪安诊断主营业务：医学诊断服务、诊断技术研发、诊断产品生产及销售、司法鉴定、健康管理等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300008192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0186","300244","BK0042","BK0028","BK0114","BK0070","BK0197","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220000","title":"迪安诊断（300244）披露独立董事任期届满辞职公告，9月30日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671220000?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:07","pubTimestamp":1790777236,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，迪安诊断报收于20.52元，较前一交易日上涨1.63%，最新总市值为128.25亿元。近日，迪安诊断技术集团股份有限公司发布《关于独立董事任期届满辞职的公告》。在此期间，李天天先生将继续履行职责。公司董事会对李天天先生在任职期间的贡献表示感谢。李天天先生未持有公司股份，无尚未履行完毕的承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000037815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0070","BK0114","BK0236","BK0197","BK0042","BK0146","300244","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221261","title":"港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221261","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671221261?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:13","pubTimestamp":1790734418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，泰格医药盘中涨超4%，截至发稿，涨3.63%，报47港元，成交额1976.94万港元。消息面上，据泰格医药官微消息，近日，泰格医药与迪安诊断在杭州签署战略合作协议。双方将围绕AI制药、临床试验、伴随诊断等领域开展深度合作，共同构建国内领先的“创新药研发—伴随诊断”一体化协同体系，让诊断与数据能力更早融入药物研发过程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","AGIX","LU1820825898.SGD","BK0197","BK0028","BK4585","03347","BK1574","BK0114","VXUS","BK0216","BK1583","AIPO","LU1146622755.USD","BK1141","BK0174","ARTY","300347","BK0146","BK4588","BK1191","01477","BK0077","KCAI","VTHR","300244","BK0186","BK0236","BK0042","BK1576","QTOC","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409131","title":"股市必读：迪安诊断新发布《2026年第一次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409131?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:44","pubTimestamp":1790531055,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第一次临时股东会审议通过《关于对外投资收购股权的议案》，同意票占比99.7911%，中小股东同意比例为95.6090%。北京德恒（杭州）律师事务所关于迪安诊断技术集团股份有限公司2026年第一次临时股东会的法律意见书北京德恒（杭州）律师事务所就本次股东会的召集与召开程序、出席会议人员及召集人资格、表决程序及结果出具法律意见书，确认其符合法律法规及公司章程规定，决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0186","BK0146","300244","BK0197","BK0042","BK0236","BK0114","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496481","title":"迪安诊断（300244）披露2026年第一次临时股东会决议公告，9月24日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496481?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:12","pubTimestamp":1790259159,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，迪安诊断报收于20.79元，较前一交易日下跌1.33%，最新总市值为129.93亿元。该股当日开盘21.0元，最高21.6元，最低20.68元，成交额达6.25亿元，换手率为5.93%。迪安诊断技术集团股份有限公司于2026年9月24日召开2026年第一次临时股东会，会议由董事会召集，采用现场与网络投票相结合方式召开。出席会议的股东共265人，代表有表决权股份总数的27.6553%。中小股东对该议案的同意比例为95.6090%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400040987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0114","BK0028","BK0042","BK0236","BK0146","300244","BK0186","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590281","title":"迪安诊断新注册《迪安诊断Repilot文献智搜平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590281","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590281?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:15","pubTimestamp":1789064116,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迪安诊断（300244）新注册了《迪安诊断Repilot文献智搜平台V1.0》项目的软件著作权。今年以来迪安诊断新注册软件著作权2个，较去年同期减少了77.78%。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了9634.42万元，同比减17.03%。通过天眼查大数据分析，迪安诊断技术集团股份有限公司共对外投资了40家企业，参与招投标项目27次；财产线索方面有商标信息281条，专利信息8条，著作权信息78条；此外企业还拥有行政许可40个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0186","BK0197","300244","BK0236","BK0114","159180","BK0042","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793110004088,"stockEarnings":[{"period":"1week","weight":0.1729},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.3173},{"period":"6month","weight":0.1127},{"period":"1year","weight":0.401},{"period":"ytd","weight":0.3683}],"compareEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":-0.0491},{"period":"3month","weight":-0.0304},{"period":"6month","weight":-0.0998},{"period":"1year","weight":-0.064},{"period":"ytd","weight":-0.0684}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"迪安诊断技术集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"45157人(较上一季度减少12.43%)","perCapita":"11103股","listingDate":"2011-07-19","address":"浙江省杭州市西湖区三墩镇金蓬街329号2幢5层","registeredCapital":"62497万元","survey":" 迪安诊断技术集团股份有限公司的主营业务是医学诊断服务及体外诊断产品销售。公司的主要产品是医学诊断服务、诊断技术研发、诊断产品生产及销售、司法鉴定、健康管理。","listedPrice":23.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪安诊断(300244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪安诊断,300244,迪安诊断股票,迪安诊断股票老虎,迪安诊断股票老虎国际,迪安诊断行情,迪安诊断股票行情,迪安诊断股价,迪安诊断股市,迪安诊断股票价格,迪安诊断股票交易,迪安诊断股票购买,迪安诊断股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪安诊断(300244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}